Overview

Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.

Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
This is a research study of a study drug known as LY041001 or human insulin inhalation powder (HIIP). HIIP is a powder form of insulin made to be inhaled through the mouth and into the lungs using a special handheld device.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Alkermes, Inc.
Treatments:
Insulin
Insulin, Globin Zinc